Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.

@article{Nam2017EfficacyOB,
  title={Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.},
  author={Jackie L. Nam and Kaoru Takase-Minegishi and Sofia Ramiro and Katerina Chatzidionysiou and Josef S Smolen and D{\'e}sir{\'e}e Mfm van der Heijde and Johannes W. J. Bijlsma and Gerd R{\"u}diger Burmester and Maxime R Dougados and M. J. H. Scholte-Voshaar and Ronald F van Vollenhoven and Robert B. M. Landew{\'e}},
  journal={Annals of the rheumatic diseases},
  year={2017},
  volume={76 6},
  pages={
          1113-1136
        }
}
OBJECTIVES To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) to inform European League Against Rheumatism (EULAR) Task Force treatment recommendations. METHODS MEDLINE, EMBASE and Cochrane databases were searched for phase III or IV (or phase II, if these studies were lacking) randomised controlled trials (RCTs) published between January 2013 and February 2016. Abstracts from the American College of… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 33 CITATIONS

Impact of Drug Induced Remission in Rheumatoid Arthritis

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 55 REFERENCES

Similar Papers